AU2002242705A1 - Utilization of buprenorphine in urinary incontinence therapy - Google Patents

Utilization of buprenorphine in urinary incontinence therapy

Info

Publication number
AU2002242705A1
AU2002242705A1 AU2002242705A AU2002242705A AU2002242705A1 AU 2002242705 A1 AU2002242705 A1 AU 2002242705A1 AU 2002242705 A AU2002242705 A AU 2002242705A AU 2002242705 A AU2002242705 A AU 2002242705A AU 2002242705 A1 AU2002242705 A1 AU 2002242705A1
Authority
AU
Australia
Prior art keywords
buprenorphine
utilization
urinary incontinence
incontinence therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002242705A
Other versions
AU2002242705B2 (en
Inventor
Johannes Bartholomaus
Thomas Christoph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001107828 external-priority patent/DE10107828A1/en
Priority claimed from DE20115429U external-priority patent/DE20115429U1/en
Priority claimed from DE2001162704 external-priority patent/DE10162704A1/en
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Priority claimed from PCT/EP2002/001699 external-priority patent/WO2002066031A1/en
Publication of AU2002242705A1 publication Critical patent/AU2002242705A1/en
Application granted granted Critical
Publication of AU2002242705B2 publication Critical patent/AU2002242705B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002242705A 2001-02-16 2002-02-18 Utilization of buprenorphine in urinary incontinence therapy Ceased AU2002242705B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE10107828.5 2001-02-16
DE2001107828 DE10107828A1 (en) 2001-02-16 2001-02-16 Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches
DE20115429.3 2001-09-18
DE20115429U DE20115429U1 (en) 2001-09-18 2001-09-18 Opioids in urinary incontinence
DE10162704.1 2001-12-19
DE2001162704 DE10162704A1 (en) 2001-12-19 2001-12-19 Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches
PCT/EP2002/001699 WO2002066031A1 (en) 2001-02-16 2002-02-18 Utilization of buprenorphine in urinary incontinence therapy

Publications (2)

Publication Number Publication Date
AU2002242705A1 true AU2002242705A1 (en) 2003-02-27
AU2002242705B2 AU2002242705B2 (en) 2006-08-24

Family

ID=27214302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002242705A Ceased AU2002242705B2 (en) 2001-02-16 2002-02-18 Utilization of buprenorphine in urinary incontinence therapy

Country Status (14)

Country Link
US (1) US20040102468A1 (en)
EP (1) EP1368023B1 (en)
JP (1) JP4908726B2 (en)
AT (1) ATE314066T1 (en)
AU (1) AU2002242705B2 (en)
CA (1) CA2438339C (en)
DE (1) DE50205438D1 (en)
DK (1) DK1368023T3 (en)
ES (1) ES2255607T3 (en)
HU (1) HU229354B1 (en)
MX (1) MXPA03006742A (en)
NZ (1) NZ528064A (en)
PL (1) PL204638B1 (en)
WO (1) WO2002066031A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323421A1 (en) * 2001-12-20 2003-07-02 Grünenthal GmbH Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
US8260389B2 (en) 2003-10-15 2012-09-04 Hegln (Dalian) Pharmaceuticals, Inc. Bladder function monitoring methods, apparatuses, media and signals
WO2005034754A1 (en) 2003-10-15 2005-04-21 The University Of British Columbia Methods and apparatus for urodynamic analysis
US11547676B2 (en) * 2012-12-28 2023-01-10 Teikoku Seiyaku Co., Ltd. Extended buprenorphine transdermal delivery compositions and methods for using the same
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
CN107320770A (en) * 2017-07-12 2017-11-07 江苏西宏生物医药有限公司 One kind injection implant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
DE4446600A1 (en) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermal absorption of active ingredients from supercooled melts
EP0820288B1 (en) * 1995-03-03 2004-02-11 Endo Pharmaceuticals Inc. Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
JPH1036265A (en) * 1996-07-19 1998-02-10 Nitto Denko Corp Buprenorphine percutaneous absorption preparation
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
IT1302682B1 (en) * 1998-10-16 2000-09-29 Formenti Farmaceutici Spa ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORPHINE

Similar Documents

Publication Publication Date Title
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
AU2003252067A1 (en) Apparatus and methods for treating female urinary incontinence
AU2003218123A1 (en) Shaped tampon
AU2002315166A1 (en) Sir2alpha-based therapeutic and prophylactic methods
AU2003296883A1 (en) Apparatus and methods for treating female urinary incontinence
AU2002231206A1 (en) Treatment of depression
AUPR074500A0 (en) Treatment of t cell disorders
AU2003240717A1 (en) Combination of selected opioids with other active substances for use in the therapy of urinary incontinence
AUPQ968700A0 (en) Treatment of urinary incontinence
AU2002242705A1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
AU2002227247A1 (en) Biofilm therapy process and elements
HUP0302984A3 (en) Utilization of buprenorphine for preparation of pharmaceutical composition useful in urinary incontinence therapy
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2001261324A1 (en) Psoriasis treatment
AU1196601A (en) Methods of diagnosing and treating urinary incontinence
SI1368023T1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU2003280137A1 (en) The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence
AU6686700A (en) Treatment of urinary incontinence
AU2001253560A1 (en) Methods of treatment
AU2002304453A1 (en) Preparation and use of amorphous lisinopril
AU2003281205A1 (en) Remedy for urinary frequency and urinary incontinence
AU2001266665A1 (en) Process for propagation and utilization of mimosa
AU2003211908A1 (en) Therapeutic agent for urinary incontinence
AU2002250088A1 (en) Devices and methods for treatment of incontinence